DK0754058T3 - Sårheling - Google Patents

Sårheling

Info

Publication number
DK0754058T3
DK0754058T3 DK95913237T DK95913237T DK0754058T3 DK 0754058 T3 DK0754058 T3 DK 0754058T3 DK 95913237 T DK95913237 T DK 95913237T DK 95913237 T DK95913237 T DK 95913237T DK 0754058 T3 DK0754058 T3 DK 0754058T3
Authority
DK
Denmark
Prior art keywords
wound healing
beta
growth factor
agent
tgf
Prior art date
Application number
DK95913237T
Other languages
English (en)
Inventor
Mark W J Ferguson
Mamta Shah
Original Assignee
Univ Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9406154A external-priority patent/GB2288118A/en
Priority claimed from GBGB9424898.6A external-priority patent/GB9424898D0/en
Application filed by Univ Manchester filed Critical Univ Manchester
Application granted granted Critical
Publication of DK0754058T3 publication Critical patent/DK0754058T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK95913237T 1994-03-29 1995-03-29 Sårheling DK0754058T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9406154A GB2288118A (en) 1994-03-29 1994-03-29 Wound healing composition
GBGB9424898.6A GB9424898D0 (en) 1994-12-09 1994-12-09 Wound healing
PCT/GB1995/000704 WO1995026203A1 (en) 1994-03-29 1995-03-29 Wound healing

Publications (1)

Publication Number Publication Date
DK0754058T3 true DK0754058T3 (da) 2000-02-07

Family

ID=26304595

Family Applications (2)

Application Number Title Priority Date Filing Date
DK99201184T DK0968723T3 (da) 1994-03-29 1995-03-29 Sårheling eller helbredelse af fibrotiske lidelser ved anvendelse af mindst ét middel mod en vækstfaktor
DK95913237T DK0754058T3 (da) 1994-03-29 1995-03-29 Sårheling

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK99201184T DK0968723T3 (da) 1994-03-29 1995-03-29 Sårheling eller helbredelse af fibrotiske lidelser ved anvendelse af mindst ét middel mod en vækstfaktor

Country Status (12)

Country Link
US (1) US5972335A (da)
EP (2) EP0754058B1 (da)
JP (1) JP4083794B2 (da)
AT (2) ATE435030T1 (da)
AU (1) AU710153B2 (da)
CA (1) CA2186269C (da)
DE (2) DE69535976D1 (da)
DK (2) DK0968723T3 (da)
ES (2) ES2140670T3 (da)
GR (1) GR3032266T3 (da)
NZ (1) NZ282856A (da)
WO (1) WO1995026203A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
GB2304047A (en) * 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
GB9601081D0 (en) * 1995-10-06 1996-03-20 Cambridge Antibody Tech Specific binding members for human transforming growth factor beta;materials and methods
GB2306481A (en) 1995-10-21 1997-05-07 Univ Manchester Pharmaceutical comprising a stimulator of activin and/or inhibin
GB9702943D0 (en) * 1997-02-13 1997-04-02 Univ Manchester Wound healing
DE10022074A1 (de) * 2000-05-06 2001-11-08 Henkel Kgaa Elektrochemisch erzeugte Schichten zum Korrosionsschutz oder als Haftgrund
US6509318B1 (en) * 2000-09-29 2003-01-21 The Regents Of The University Of California TGF-B inhibitors and methods
US7569132B2 (en) * 2001-10-02 2009-08-04 Henkel Kgaa Process for anodically coating an aluminum substrate with ceramic oxides prior to polytetrafluoroethylene or silicone coating
US7452454B2 (en) * 2001-10-02 2008-11-18 Henkel Kgaa Anodized coating over aluminum and aluminum alloy coated substrates
GB0217136D0 (en) * 2002-07-24 2002-09-04 Renovo Ltd Wound healing & treatment of fibrosis
US20050074453A1 (en) * 2003-10-02 2005-04-07 Ferree Bret A. Methods of preventing adhesions following laminectomies and other surgical procedures
CN1961003B (zh) 2004-03-31 2013-03-27 健泰科生物技术公司 人源化抗TGF-β抗体
US20130028978A1 (en) * 2009-11-10 2013-01-31 The Trustees Of Columbia University In The City Of New York Compositions and methods for wound treatment
EP2542564B1 (en) * 2010-03-05 2018-05-09 Wake Forest University Health Sciences Controlled delivery system
WO2013025928A2 (en) 2011-08-17 2013-02-21 Keranetics Llc Methods for extracting keratin proteins
CA2845267C (en) 2011-08-17 2021-07-06 Keranetics Llc Low protein percentage gelling compositions
US20150284455A1 (en) * 2012-11-06 2015-10-08 Scholar Rock, Inc. Compositions and methods for modulating cell signaling
US9827245B2 (en) 2013-03-15 2017-11-28 KeraNetics, LLC Keratin compositions comprising halofuginone
HRP20251426T1 (hr) 2013-05-06 2026-01-02 Scholar Rock, Inc. Sastavi i postupci za modulaciju faktora rasta
WO2017201036A1 (en) 2016-05-17 2017-11-23 Genentech, Inc. Stromal gene signatures for diagnosis and use in immunotherapy
ES2984919T3 (es) 2017-11-06 2024-10-31 Hoffmann La Roche Procedimientos diagnósticos y terapéuticos para el cáncer
WO2023080900A1 (en) 2021-11-05 2023-05-11 Genentech, Inc. Methods and compositions for classifying and treating kidney cancer
WO2024077095A1 (en) 2022-10-05 2024-04-11 Genentech, Inc. Methods and compositions for classifying and treating bladder cancer
WO2024077166A1 (en) 2022-10-05 2024-04-11 Genentech, Inc. Methods and compositions for classifying and treating lung cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU624789B2 (en) * 1987-02-19 1992-06-25 Amgen, Inc. Purified platelet-derived growth factor and methods for purification thereof
US5094941A (en) * 1987-12-31 1992-03-10 Zymogenetics, Inc. Monoclonal antibodies to PDGF
WO1991004748A1 (en) * 1989-09-29 1991-04-18 La Jolla Cancer Research Foundation INHIBITING TRANSFORMING GROWTH FACTOR β TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
WO1993010808A1 (en) * 1991-12-04 1993-06-10 La Jolla Cancer Research Foundation INHIBITING TRANSFORMING GROWTH FACTOR β TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX
GB9206861D0 (en) * 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
WO1993019783A1 (en) * 1992-04-01 1993-10-14 The Whittier Institute For Diabetes And Endocrinology Methods of inhibiting or enhancing scar formation in the cns
GB9217206D0 (en) 1992-08-13 1992-09-23 Pointer John C Photo labels
AU5587094A (en) * 1992-10-26 1994-05-24 Kirin Brewery Company, Limited Method for producing large latent transforming growth factor-beta complexes and large latency associated peptide
JP4350370B2 (ja) * 2002-12-27 2009-10-21 株式会社半導体エネルギー研究所 電子回路及び電子機器

Also Published As

Publication number Publication date
JP4083794B2 (ja) 2008-04-30
GR3032266T3 (en) 2000-04-27
ATE186220T1 (de) 1999-11-15
EP0754058B1 (en) 1999-11-03
JPH09510967A (ja) 1997-11-04
ATE435030T1 (de) 2009-07-15
DK0968723T3 (da) 2009-11-09
AU710153B2 (en) 1999-09-16
EP0968723A1 (en) 2000-01-05
EP0968723B1 (en) 2009-07-01
DE69513158T2 (de) 2000-05-04
DE69513158D1 (de) 1999-12-09
ES2140670T3 (es) 2000-03-01
WO1995026203A1 (en) 1995-10-05
US5972335A (en) 1999-10-26
CA2186269C (en) 2008-06-03
DE69535976D1 (de) 2009-08-13
NZ282856A (en) 1998-06-26
EP0754058A1 (en) 1997-01-22
ES2329531T3 (es) 2009-11-26
CA2186269A1 (en) 1995-10-05
AU2077895A (en) 1995-10-17

Similar Documents

Publication Publication Date Title
ATE186220T1 (de) Wundheilung
ATE241334T1 (de) Mittel zur förderung des haarwachstums
ATE247483T1 (de) Matrixprotein enthaltende zusammensetzungen für entzündliche und infektiöse zustände
FI940932L (fi) Koostumuksia ja menetelmiä haavojen hoitamiseksi
CY1108110T1 (el) Παραγοντες και μεθοδοι για προστασια, θεραπεια και επιδιορθωση συνδετικου ιστου
DE69524682D1 (de) Mittel zur Behandlung von Wunden
FI973828A0 (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
NO971192D0 (no) Fremgangsmåter for avlevering av materialer inn i huden, og sammensetninger som blir anvendt
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
FI941396A0 (fi) Koostumuksia biologisesti aktiivisen TGF-valvottua vapauttamista varten
DE69019363D1 (de) Desinfizierende zusammensetzung und desinfektionsverfahren.
EP0506658A4 (en) Compositions and method for treating painful, inflammatory or allergic disorders
GR3029436T3 (en) Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds.
ES2195000T3 (es) Composicion farmaceutica.
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
DE69104656D1 (de) Heilende Zusammensetzung zur örtlichen Anwendung.
WO2001030334A3 (en) 6-methoxy-2-naphthylacetic acid prodrugs compositions for treating inflammation
RU96122690A (ru) Лекарственное средство для наружного лечения псориаза
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь